Rally-Funded Discovery: From Early Belief to Lifesaving Care

In 2018, Hamid Bassiri, M.D., Ph.D., at the Children’s Hospital of Philadelphia received early funding from Rally Foundation for Childhood Cancer Research. That support came at the perfect moment. It gave his lab the chance to explore a big and hopeful idea. Could the immune system help save kids with neuroblastoma? 

Dr. Bassiri and his team discovered how a treatment called dinutuximab, also known as Unituxin, helps the immune system find and destroy cancer cells. Today, this treatment is part of standard care for kids with neuroblastoma. It is helping real kids in real hospitals right now. 

Rally’s early support helped the team gather the first results they needed to win a major Department of Defense grant. That funding helped them keep going and helped future scientists learn how to fight childhood cancer in safer and stronger ways. 

Because Rally believed in this work from the beginning, kids and families have more hope today. Early funding really can change a child’s story.

This is why early-stage research funding matters.

This is the power of philanthropic seed investing.

This is Rally.